Dr. Gerhard Hindricks of Herzentrum Leipzig GmbH in Leipzig said, As one of the original evaluation sites for the magnetic irrigated catheter, we were among the first to see its clear clinical advantages. Having now performed additional cases since its re-introduction, we're delighted by its performance relative to navigation and lesion formation and we're very excited to participate in its commercial release.
Dr. Karl Heinz-Kuck from St. Georg Allgemeines Krankenhaus in Hamburg said, Its superb maneuverability provides precise positioning even at sites difficult to reach within the heart, and together with the catheter's stability this led to a high success rate.
Mike Kaminski, Stereotaxis President and COO said, With these very positive results from the external evaluation and feedback from participating clinicians, we are very excited about the commercial release of the magnetic irrigated catheter.